(Q58664996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Roger A. Barker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

11

Steven Piantadosi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Wendy R Galpern

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jacqueline Corrigan-Curay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jeffrey Kahn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Danilo Tagle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Thomas B Freeman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Scott Y H Kim

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Amy Comstock Rick

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Howard J Federoff

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Christopher G Goetz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Karl Kieburtz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

643-650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

1 reference

7 January 2021

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Effects of expectation on placebo-induced dopamine release in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Evaluation of surgery for Parkinson's disease: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Cell transplantation and gene therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Neural grafting in Parkinson's disease Problems and possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

The ethical problems with sham surgery in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Sham Surgery: An Ethical Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Placebo-controlled procedural trials for neurological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Open-label surgical trials for Parkinson disease: time for reconsideration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Experimental therapies for Parkinson's disease: Why fake it?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

What makes clinical research ethical?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Risk of surgical delivery to deep nuclei: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Consent in impaired populations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Ethics of sham surgery: perspective of patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Ethical issues in clinical neuroscience research: a patient's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Studying neurosurgical implants for Parkinson disease: a question of design

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970064-9

7 January 2021

10.1016/S1474-4422(12)70064-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710757%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference